Acarix awarded Danish Design Award 2017 for its innovative heart disease testing device; CADScor®System
May 9, 2017Acarix awarded Danish Design Award 2017 for its innovative heart disease testing device; CADScor®System(Malmö, Swed...
Notice of Annual General Meeting in Acarix AB
Notice of Annual General Meeting in Acarix AB The shareholders of Acarix AB, reg. no. 559009-0667, (the "Company"), are hereby convened...
Kallelse till årsstämma i Acarix AB
Kallelse till årsstämma i Acarix ABAktieägarna i Acarix AB, org.nr 559009-0667, ("Bolaget") kallas härmed till &ar...
Multicenterstudie med Acarix CADScor®System bekräftar tidigare preliminära resultat att CADScor®System kan utesluta CAD med 97% negativt prediktivt värde.
Press releaseMalmö 17 mars 2017Multicenterstudie med Acarix CADScor®System bekräftar tidigare preliminära resultat a...
Acarix CADScor®System multi-center trial results confirms previous preliminary results of CADScor®System ruling out CAD with 97% negative predictive value
Press releaseMalmö March 17, 2017Acarix CADScor®System multi-center trial results confirms previous preliminary results of CAD...
Acarix AB (publ) to present at Vator Securities Unicorn Summit on 7 March 2017
Acarix AB's (publ) ("Acarix") CEO, Søren Rysholt Christiansen, will be presenting at Vator Securities Unicorn Summit in Stockhol...
Coronary Artery Disease Specialist Acarix AB to present at Medtech Showcase 2017
Press releaseMalmö, December 23, 2016Coronary Artery Disease Specialist Acarix AB to present at Medtech Showcase 2017Recent oversu...